Cargando…

Rituximab in Pemphigus – An Observational Study from a Tertiary Care Center of North India

BACKGROUND: Pemphigus is a group of potentially fatal autoimmune mucocutaneous blistering diseases. Rituximab (RTX) is a chimeric anti-CD20 (anti-cluster of differentiate 20) monoclonal antibody being increasingly used and becoming the first-line therapy in the management of pemphigus. AIMS AND OBJE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hassan, Iffat, Rehman, Fozia, Sultan, Sheikh Javeed, Aslam, Aaqib, Tasaduq, Irfan, Reyaz, Saika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595168/ https://www.ncbi.nlm.nih.gov/pubmed/36304644 http://dx.doi.org/10.4103/idoj.idoj_170_22

Ejemplares similares

Increasing the Safety Profile of Follicular Unit Extraction by Eliminating the Use of Bupivacaine and Nerve Block: Experience from a Tertiary Care Center of North India
por: Shah, Faizan Y, et al.
Publicado: (2023)

Dermoscopy of Oral Mucosal Lesions: Experience from a Tertiary Care Center in North India and Review of Literature
por: Rather, Shagufta, et al.
Publicado: (2022)

Role of Intralesional Vitamin D3 in the Treatment of Cutaneous Warts
por: Latif, Insha, et al.
Publicado: (2021)

Prevalence and Pattern of Dermatological Manifestations Among Substance Users Across Kashmir Valley in North India
por: Aslam, Aaqib, et al.
Publicado: (2022)

Successful Treatment of Recalcitrant Pediatric Pemphigus Vulgaris With Rituximab
por: Santiago-Vázquez, Marely, et al.
Publicado: (2022)

Etiopathological and Clinical Study of Acute Generalized Exanthematous Pustulosis: Experience from a Tertiary Care Hospital in North India
por: Bhat, Yasmeen J., et al.
Publicado: (2020)

Intra-individual Right-Left Comparative Study of Combined Therapy of Intramatricial Triamcinolone and Platelet-Rich Plasma vs. Intramatricial Triamcinolone Only in Lichen Planus-Associated Nail Dystrophy
por: Rehman, Fozia, et al.
Publicado: (2021)

Fractional Laser Resurfacing for Acne Scars: Our Experience at Tertiary Care Hospital of North India
por: Bhat, Yasmeen Jabeen, et al.
Publicado: (2023)

Rituximab in the Treatment of Pemphigus Vulgaris
por: Zakka, Labib R., et al.
Publicado: (2012)

Prevalence of Cold Dermatoses in Kashmir Valley: A Cross-Sectional Study from North India
por: Shah, Faizan Y., et al.
Publicado: (2020)

Pattern of uveitis in North East India: A tertiary eye care center study
por: Das, Dipankar, et al.
Publicado: (2009)

Rituximab therapy improves recalcitrant Pemphigus vulgaris
por: Noormohammadpour, Pedram, et al.
Publicado: (2015)

Rituximab in Pemphigus: Road Covered and Challenges Ahead
por: Vinay, Keshavamurthy, et al.
Publicado: (2018)

Cerebral toxoplasmosis after rituximab for pemphigus vulgaris
por: Lee, Erica B., et al.
Publicado: (2019)

Rituximab Therapy for Treatment of Pemphigus in Southeast Asians
por: Kanokrungsee, Silada, et al.
Publicado: (2021)

The Era of Device Colonizers: Chryseobacterium indologenes Infections from a Tertiary Care Center in North India
por: Jain, Vidhi, et al.
Publicado: (2018)

AZD-1222/rituximab: Pemphigus vulgaris and pemphigus vulgaris flare-up: 2 case reports
Publicado: (2022)

Off-label use of rituximab in dermatology: pemphigus treatment
por: Bomm, Lislaine, et al.
Publicado: (2013)

Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil
por: Biot, Stephanie Del Rio Navarrete, et al.
Publicado: (2014)

Rituximab therapy in pemphigus and other autoantibody-mediated diseases
por: Ran, Nina A., et al.
Publicado: (2017)

Follow-up Data of Rituximab as Adjuvant Therapy in Pemphigus
por: Khopkar, Uday S, et al.
Publicado: (2017)

Efficacy of rituximab in pediatric pemphigus: A literature review
por: Patel, Meera H., et al.
Publicado: (2021)

Rituximab: Aggressive course of pemphigus vulgaris: case report
Publicado: (2021)

Efficacy of Repeated Courses of Rituximab as Treatment for Pemphigus Vulgaris
por: BAUM, Sharon, et al.
Publicado: (2020)

Occupational Dermatoses among Cottage Industry Workers of Kashmir Valley in North India
por: Akhtar, Saniya, et al.
Publicado: (2017)

Impact of COVID-19 Pandemic on Dermatologists and Dermatology Practice
por: Bhat, Yasmeen Jabeen, et al.
Publicado: (2020)

Half and half blisters in pemphigus vulgaris: A diagnostic quandary
por: Rather, Shagufta, et al.
Publicado: (2016)

Clinico-Epidemiological Profile of Patients with Vitiligo: A Retrospective Study from a Tertiary Care Center of North India
por: Mahajan, Vikram K., et al.
Publicado: (2019)

Real world evidence: Patients with refractory pemphigus treated with Rituximab
por: Perifani, Vagiani, et al.
Publicado: (2021)

Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy
por: Benesh, Gabrielle, et al.
Publicado: (2021)

Role of Rituximab in the Treatment of Pemphigus Vulgaris: Patient Selection and Acceptability
por: Ciolfi, Christian, et al.
Publicado: (2022)

Thrombotic Storm Induced by Rituximab in a Patient With Pemphigus Vulgaris
por: Karan, Abhinav, et al.
Publicado: (2023)

Brain Abscess following Rituximab Infusion in a Patient with Pemphigus Vulgaris
por: Al-Harbi, Talal M., et al.
Publicado: (2015)

Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab
por: Waldman, Reid A., et al.
Publicado: (2021)

The positive impact of rituximab on the quality of life and mental health in patients with pemphigus
por: Rashid, Hanan, et al.
Publicado: (2022)

IgG N-glycosylation from Patients with Pemphigus Treated with Rituximab
por: Font, Guillaume, et al.
Publicado: (2022)

Pregnancy outcomes in women with pemphigus exposed to rituximab before or during pregnancy
por: Dehghanimahmoudabadi, Azin, et al.
Publicado: (2022)

Rituximab in Pemphigus Vulgaris: A Review of Monoclonal Antibody Therapy in Dermatology
por: Khandelwal, Krishna, et al.
Publicado: (2023)

Incidence of Bullous Pemphigoid and Pemphigus in Korea
por: Joo, Jae Seong, et al.
Publicado: (2021)

Clinical impact and a prognostic marker of early rituximab treatment after rituximab reimbursement in Korean pemphigus patients
por: Song, Ahreum, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cj1enf6brkknvnes3vopi1pk17